BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10575276)

  • 1. Superantigens are presented by and activate thymocytes from infants.
    Thulesen S; Jørgensen A; Gerwien J; Dohlsten M; Holst Nissen M; Odum N; Röpke C
    Exp Clin Immunogenet; 1999; 16(4):226-33. PubMed ID: 10575276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human thymic epithelial cells present superantigens to T-cell lines and thymocytes.
    Jłrgensen A; Nielsen M; Svejgaard A; Ledbetter JA; Odum N; Röpke C
    Exp Clin Immunogenet; 1996; 13(3-4):192-203. PubMed ID: 9165273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation.
    Poncet P; Arock M; David B
    J Leukoc Biol; 1999 Jul; 66(1):105-12. PubMed ID: 10410997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a developmentally regulated phase of postselection expansion driven by thymic epithelium.
    Hare KJ; Wilkinson RW; Jenkinson EJ; Anderson G
    J Immunol; 1998 Apr; 160(8):3666-72. PubMed ID: 9558066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class II molecules are required for initiation of positive selection but not during terminal differentiation of human CD4 single positive thymocytes.
    Vanhecke D; Verhasselt B; De Smedt M; De Paepe B; Leclercq G; Plum J; Vandekerckhove B
    J Immunol; 1997 Apr; 158(8):3730-7. PubMed ID: 9103437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superantigen presentation by human retinal pigment epithelial cells to T cells is dependent on CD2-CD58 and CD18-CD54 molecule interactions.
    Jørgensen A; Junker N; Kaestel CG; Liang Y; Wiencke A; la Cour M; Lui GM; Ødum N; Nissen MH; Röpke C
    Exp Eye Res; 2001 Nov; 73(5):723-33. PubMed ID: 11747372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-mediated presentation of MHC class II molecules guides thymocytes to the CD4 lineage.
    Komaniwa S; Hayashi H; Kawamoto H; Sato SB; Ikawa T; Katsura Y; Udaka K
    Eur J Immunol; 2009 Jan; 39(1):96-112. PubMed ID: 19089815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous deletion of Mtv-superantigen-reactive thymocytes in the CD3(medium/high) CD4(+)CD8(+) subset.
    Sheard MA; Sharrow SO; Takahama Y
    Scand J Immunol; 2000 Dec; 52(6):550-4. PubMed ID: 11119259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen.
    Zal T; Volkmann A; Stockinger B
    J Exp Med; 1994 Dec; 180(6):2089-99. PubMed ID: 7964486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of major histocompatibility complex class II and CD80 by gingival epithelial cells induces activation of CD4+ T cells in response to bacterial challenge.
    Matsuyama T; Kawai T; Izumi Y; Taubman MA
    Infect Immun; 2005 Feb; 73(2):1044-51. PubMed ID: 15664948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymocytes positively select thymocytes in human system.
    Choi EY; Park WS; Jung KC; Chung DH; Bae YM; Kim TJ; Song HG; Kim SH; Ham DI; Hahn JH; Kim J; Kim K; Hwang TS; Park SH
    Hum Immunol; 1997 Apr; 54(1):15-20. PubMed ID: 9154453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition of the HLA-DR-associated human thymus peptidome.
    Collado JA; Alvarez I; Ciudad MT; Espinosa G; Canals F; Pujol-Borrell R; Carrascal M; Abian J; Jaraquemada D
    Eur J Immunol; 2013 Sep; 43(9):2273-82. PubMed ID: 23719902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination between maintenance- and differentiation-inducing signals during initial and intermediate stages of positive selection.
    Anderson G; Hare KJ; Platt N; Jenkinson EJ
    Eur J Immunol; 1997 Aug; 27(8):1838-42. PubMed ID: 9295015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential processing of self-antigens by subsets of thymic stromal cells.
    Guerder S; Viret C; Luche H; Ardouin L; Malissen B
    Curr Opin Immunol; 2012 Feb; 24(1):99-104. PubMed ID: 22296716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 ligand expression is developmentally regulated in human thymocytes.
    Fuleihan R; Ahern D; Geha RS
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):52-8. PubMed ID: 7606868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the MHC restriction during maturation of antigen-specific human T cells in the thymus.
    Hesnard L; Legoux F; Gautreau L; Moyon M; Baron O; Devilder MC; Bonneville M; Saulquin X
    Eur J Immunol; 2016 Mar; 46(3):560-9. PubMed ID: 26635029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.